Volume 1 · Issue 5

Neurodegeneration & the Aging Brain

From cognitive reserve to longitudinal biomarkers, this issue examines the progression of neurodegenerative conditions and the evidence used to distinguish aging from disease.

100 Creative Commons readings · Paulina Valenzuela, MD, Editor-in-Chief

Issue 5 · Reading list

Explore the research

Download issue catalog

100 readings · Page 1 of 5

  1. Alzheimer’s disease and related dementias · CC BY 4.0

    The Amyloid-β Pathway in Alzheimer's Disease.

    Harald Hampel, John Hardy, Kaj Blennow, Christopher Chen et al.

    Molecular psychiatry · 2021

    Original article
  2. Alzheimer’s disease and related dementias · CC BY 4.0

    New insights into the genetic etiology of Alzheimer's disease and related dementias.

    Céline Bellenguez, Fahri Küçükali, Iris E Jansen, Luca Kleineidam et al.

    Nature genetics · 2022

    Original article
  3. Alzheimer’s disease and related dementias · CC BY 4.0

    The amyloid hypothesis of Alzheimer's disease at 25 years.

    Dennis J Selkoe, John Hardy

    EMBO molecular medicine · 2016

    Original article
  4. Alzheimer’s disease and related dementias · CC BY 4.0

    The neuropathological diagnosis of Alzheimer's disease.

    Michael A DeTure, Dennis W Dickson

    Molecular neurodegeneration · 2019

    Original article
  5. Alzheimer’s disease and related dementias · CC BY 4.0

    Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

    GBD 2016 Dementia Collaborators

    The Lancet. Neurology · 2018

    Original article
  6. Alzheimer’s disease and related dementias · CC BY 4.0

    Comprehensive Review on Alzheimer's Disease: Causes and Treatment.

    Zeinab Breijyeh, Rafik Karaman

    Molecules (Basel, Switzerland) · 2020

    Original article
  7. Alzheimer’s disease and related dementias · CC BY 4.0

    Gut microbiome alterations in Alzheimer's disease.

    Nicholas M Vogt, Robert L Kerby, Kimberly A Dill-McFarland, Sandra J Harding et al.

    Scientific reports · 2017

    Original article
  8. Alzheimer’s disease and related dementias · CC BY 4.0

    Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors.

    Stephen S Dominy, Casey Lynch, Florian Ermini, Malgorzata Benedyk et al.

    Science advances · 2019

    Original article
  9. Alzheimer’s disease and related dementias · CC0 1.0

    Alzheimer's disease drug-development pipeline: few candidates, frequent failures.

    Jeffrey L Cummings, Travis Morstorf, Kate Zhong

    Alzheimer's research & therapy · 2014

    Original article
  10. Alzheimer’s disease and related dementias · CC BY 4.0

    Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies.

    Jifa Zhang, Yinglu Zhang, Jiaxing Wang, Yilin Xia et al.

    Signal transduction and targeted therapy · 2024

    Original article
  11. Alzheimer’s disease and related dementias · CC BY 4.0

    Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.

    Wenzhang Wang, Fanpeng Zhao, Xiaopin Ma, George Perry et al.

    Molecular neurodegeneration · 2020

    Original article
  12. Alzheimer’s disease and related dementias · CC BY 4.0

    Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology.

    Nicholas J Ashton, Wagner S Brum, Guglielmo Di Molfetta, Andrea L Benedet et al.

    JAMA neurology · 2024

    Original article
  13. Alzheimer’s disease and related dementias · CC BY 4.0

    Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.

    Y Iturria-Medina, R C Sotero, P J Toussaint, J M Mateos-Pérez et al.

    Nature communications · 2016

    Original article
  14. Alzheimer’s disease and related dementias · CC BY 4.0

    Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future.

    Yun Zhang, Huaqiu Chen, Ran Li, Keenan Sterling et al.

    Signal transduction and targeted therapy · 2023

    Original article
  15. Alzheimer’s disease and related dementias · CC BY 4.0

    Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression.

    Xinyi Wang, Guangqiang Sun, Teng Feng, Jing Zhang et al.

    Cell research · 2019

    Original article
  16. Alzheimer’s disease and related dementias · CC BY 4.0

    A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.

    Chad J Swanson, Yong Zhang, Shobha Dhadda, Jinping Wang et al.

    Alzheimer's research & therapy · 2021

    Original article
  17. Alzheimer’s disease and related dementias · CC BY 4.0

    Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model.

    Elizabeth Spangenberg, Paul L Severson, Lindsay A Hohsfield, Joshua Crapser et al.

    Nature communications · 2019

    Original article
  18. Alzheimer’s disease and related dementias · CC BY 4.0

    Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease.

    Wen-Dai Bao, Pei Pang, Xiao-Ting Zhou, Fan Hu et al.

    Cell death and differentiation · 2021

    Original article
  19. Alzheimer’s disease and related dementias · CC BY 4.0

    Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound.

    Nir Lipsman, Ying Meng, Allison J Bethune, Yuexi Huang et al.

    Nature communications · 2018

    Original article
  20. Alzheimer’s disease and related dementias · CC BY 4.0

    Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.

    Tiantian Guo, Denghong Zhang, Yuzhe Zeng, Timothy Y Huang et al.

    Molecular neurodegeneration · 2020

    Original article